Generic (that is, non-patented and therefore cheaper) drug-manufacturers have been given two years by the \USA Administration to move production to the USA itself or face a 200% import duty. Price for drugs ranging from common painkillers to antibiotics and cancer drugs will increase steeply in price. We remember that it was countries like South Africa, India and Brazil who fought US and European pressure to make drugs, as for HIV/AIDS, generic with their own production facilities.